Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to further evaluate the safety and efficacy of EUR-1008 as
compared to Kreon® in the treatment of exocrine pancreatic insufficiency associated with
Cystic Fibrosis in subjects 12 years of age and older.